ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR)

71 filings reported holding PRQR - ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share as of Q2 2025.
ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 40,456,202 shares of 105,365,368 outstanding shares and own 38% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (6,601,938 shares), Privium Fund Management B.V. (4,997,562 shares), Affinity Asset Advisors, LLC (3,499,512 shares), MORGAN STANLEY (3,083,490 shares), Sio Capital Management, LLC (2,075,139 shares), Aberdeen Group plc (1,850,348 shares), Kynam Capital Management, LP (1,649,462 shares), DAFNA Capital Management LLC (1,567,561 shares), Siren, L.L.C. (1,552,183 shares), and Woodline Partners LP (1,504,000 shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.